Tech Center 1600 • Art Units: 1623 1626
This examiner grants 84% of resolved cases
Kamal A Saeed is an examiner in Tech Center 1600 and Art Unit 1623. The examiner has 1212 resolved cases. The allowance rate for these matters is 83.8%. This metric provides a baseline for the likelihood of securing a patent grant during prosecution. The 83.8% rate is a primary data point for evaluating the probability of success in this specific Art Unit.
The interview lift is 9.8%. This value measures the increase in the probability of allowance following an interview. A lift of 9.8% indicates that engaging in a direct dialogue with the examiner can be a factor in the progression of cases. Practitioners should weigh this 9.8% figure when deciding whether to request a formal interview for their 1212 resolved cases.
The median days to allowance is 759. This figure represents the typical time span from filing to the issuance of a patent. A median of 759 days informs the scheduling and budget expectations for applicants. This 759 days duration is a factor in the overall prosecution timeline.
In Tech Center 1600, the examiner's 83.8% allowance rate and 1212 resolved cases define the current landscape. The interview lift serves as a tool for navigating the prosecution process toward a grant.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17913292 | Solid Dispersions of Amorphous 3,4-Diphenyl-4,5-Dihydro-1H-Pyrazole Derivatives, Compositions Comprising them and Uses Thereof as Cannabinoid CB1 Receptor Inhibitors | Final Rejection | Novo Nordisk A/S |
| 18847898 | A METHOD OF PRODUCING EXPLOSIVE HMX BY FLOW SYNETHESIS | Non-Final OA | BAE SYSTEMS PLC |
| 18210215 | BLEND CONTAINING CARBAMATE COMPOUND FOR PREVENTION, MITIGATION, OR TREATMENT OF SCHIZOPHRENIA | Final Rejection | SK BIOPHARMACEUTICALS CO., LTD. |
| 18872318 | HSD17B13 INHIBITORS | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18500142 | METHOD FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS AND METHOD FOR SUPPRESSING PROGRESS OF AMYOTROPHIC LATERAL SCLEROSIS | Final Rejection | Shionogi Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy